ADAPT Contract Research Organization - Sources Sought
Closed Pre-Solicitation Posted
- Solicitation number
- 75N992-24-RFI-101
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' National Institutes of Health, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking Contract Research Organization (CRO) services to support a single evolutionary clinical trial for the ADvanced Analysis for Precision cancer Therapy (ADAPT) program. The trial will enroll patients with metastatic breast, lung, and colon cancers and adjust drug treatments based on tumor evolution over multiple sequences of therapy. The CRO services required include establishing and coordinating the clinical trial across multiple ADAPT performers, managing patient enrollment and retention, processing biological samples, and providing data management and reporting. ARPA-H is requesting information on vendors' past experience with adaptive and biomarker-driven clinical trials, use of innovative data and trial management approaches, and the ability to provide transparent access to operational and patient data. Responses to this Sources Sought notice are due by May 31, 2024.
This Sources Sought notice is not a set-aside procurement and does not name any potential incumbents or current contractors. The notice indicates this is a market research effort, and no specific award value or budget range is provided. The trial duration is expected to be 60 months, with an 8-month startup period.
Notice text
ARPA-H is looking for CRO services to support a single evolutionary clinical trial that will enroll patients with metastatic breast, lung, and colon cancers. This trial will adjust drug treatments based on tumor evolution during multiple sequences of therapy. The CRO service will establish and coordinate clinical trial efforts across multiple ADAPT performers in different geographical locations, allowing for clinical interventions and tumor biology assessments in real time.
Additional details can be found in the attached ADAPT CRO Sources Sought.
Files
| File | Type | Posted |
|---|---|---|
| ADAPT CRO Sources Sought.docx | DOCX document | |
| ADAPT CRO Sources Sought.docx | DOCX document | |
| ADAPT CRO Sources Sought.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity